Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
5
×
clinical trials
5
×
deals
5
×
life sciences
national blog main
national top stories
novartis
5
×
boston blog main
boston top stories
cancer
crispr
fda
national
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
alnylam pharmaceuticals
biogen
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
detroit blog main
detroit top stories
editas medicine
europe blog main
gene therapy
gilead sciences
indiana blog main
indiana top stories
multiple myeloma
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
sanofi
seattle blog main
What
bio
deal
drug
help
medicines
new
roundup
therapeutics
access
acquire
acquisitions
advanced
agreed
analytics
announced
approval
billion
biofourmis
biogen’s
biopharmaceutical
brings
capacity
car
cash
cell
ceo
cholesterol
collabs
companies
company
compound
consolidation
convo
covid
crispr
daniel
data
devices
digital
earlier
Language
unset
Current search:
biotech
×
novartis
×
photo
×
" clinical trials "
×
deals
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
